{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,30]],"date-time":"2026-08-30T06:22:03Z","timestamp":1788070923020,"version":"build-2784847793"},"reference-count":13,"publisher":"Wiley","issue":"13","license":[{"start":{"date-parts":[[2010,9,14]],"date-time":"2010-09-14T00:00:00Z","timestamp":1284422400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["obgyn.onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["BJOG"],"published-print":{"date-parts":[[2010,12]]},"abstract":"<jats:p>\n                    <jats:italic>Please cite this paper as:<\/jats:italic>\n                    Vijgen S, Koopmans C, Opmeer B, Groen H, Bijlenga D, Aarnoudse J, Bekedam D, van den Berg P, de Boer K, Burggraaff J, Bloemenkamp K, Drogtrop A, Franx A, de Groot C, Huisjes A, Kwee A, van Loon A, Lub A, Papatsonis D, van der Post J, Roumen F, Scheepers H, Stigter R, Willekes C, Mol B, Van Pampus M for the HYPITAT study group. An economic analysis of induction of labour and expectant monitoring in women with gestational hypertension or pre\u2010eclampsia at term (HYPITAT trial). BJOG 2010;117:1577\u20131585.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>Objective\u2002<\/jats:bold>\n                    To assess the economic consequences of labour induction compared with expectant monitoring in women with gestational hypertension or pre\u2010eclampsia at term.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>Design\u2002<\/jats:bold>\n                    An economic analysis alongside the Hypertension and Pre\u2010eclampsia Intervention Trial At Term (HYPITAT).\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>Setting\u2002<\/jats:bold>\n                    Obstetric departments of six university and 32 teaching and district hospitals in the Netherlands.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>Population\u2002<\/jats:bold>\n                    Women diagnosed with gestational hypertension or pre\u2010eclampsia between 36\n                    <jats:sup>+0<\/jats:sup>\n                    and 41\n                    <jats:sup>+0<\/jats:sup>\n                    \u2003weeks of gestation, randomly allocated to either induction of labour or expectant monitoring.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>Methods\u2002<\/jats:bold>\n                    A trial\u2010based cost\u2010effectiveness analysis was performed from a societal perspective during a 1\u2010year time horizon.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>Main outcome measures\u2002<\/jats:bold>\n                    One\u2010year costs were estimated and health outcomes were expressed as the prevalence of poor maternal outcome defined as either maternal complications or progression to severe disease.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>Results\u2002<\/jats:bold>\n                    The average costs of induction of labour (\n                    <jats:italic>n<\/jats:italic>\n                    \u2003=\u2003377) were \u20ac7077 versus \u20ac7908 for expectant monitoring (\n                    <jats:italic>n<\/jats:italic>\n                    \u2003=\u2003379), with an average difference of \u2212\u20ac831 (95% CI \u2212\u20ac1561 to \u2212\u20ac144). This 11% difference predominantly originated from the antepartum period: per woman costs were \u20ac1259 for induction versus \u20ac2700 for expectant monitoring. During delivery, more costs were generated following induction (\u20ac2190) compared with expectant monitoring (\u20ac1210). No substantial differences were found in the postpartum, follow\u2010up and for non\u2010medical costs.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>Conclusion\u2002<\/jats:bold>\n                    In women with gestational hypertension or mild pre\u2010eclampsia at term, induction of labour is less costly than expectant monitoring because of differences in resource use in the antepartum period. As the trial already demonstrated that induction of labour results in less progression to severe disease without resulting in a higher caesarean section rate, both clinical and economic consequences are in favour of induction of labour in these women.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>Trial registration\u2002<\/jats:bold>\n                    The trial has been registered in the clinical trial register as ISRCTN08132825.\n                  <\/jats:p>","DOI":"10.1111\/j.1471-0528.2010.02710.x","type":"journal-article","created":{"date-parts":[[2010,9,14]],"date-time":"2010-09-14T10:58:06Z","timestamp":1284461886000},"page":"1577-1585","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":46,"title":["An economic analysis of induction of labour and expectant monitoring in women with gestational hypertension or pre\u2010eclampsia at term (HYPITAT trial)"],"prefix":"10.1111","volume":"117","author":[{"given":"SMC","family":"Vijgen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"CM","family":"Koopmans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"BC","family":"Opmeer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H","family":"Groen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D","family":"Bijlenga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"JG","family":"Aarnoudse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"DJ","family":"Bekedam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"PP","family":"van den Berg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K","family":"de Boer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"JM","family":"Burggraaff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"KWM","family":"Bloemenkamp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"AP","family":"Drogtrop","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Franx","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"CJM","family":"de Groot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"AJM","family":"Huisjes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Kwee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"AJ","family":"van Loon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Lub","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"DNM","family":"Papatsonis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"JAM","family":"van der Post","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"FJME","family":"Roumen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"HCJ","family":"Scheepers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"RH","family":"Stigter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C","family":"Willekes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"BWJ","family":"Mol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"MG","family":"Van Pampus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"for the HYPITAT study group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2010,9,14]]},"reference":[{"key":"e_1_2_10_2_2","doi-asserted-by":"publisher","DOI":"10.1067\/mob.2000.107928"},{"key":"e_1_2_10_3_2","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/S0020-7292(96)90112-5","article-title":"Hypertension in pregnancy. Number 219\u2013January 1996 (replaces no. 91, February 1986). Committee on Technical Bulletins of the American College of Obstetricians and Gynecologists","volume":"53","author":"ACOG technical bulletin","year":"1996","journal-title":"Int J Gynaecol Obstet"},{"key":"e_1_2_10_4_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1471-0528.2005.00785.x"},{"key":"e_1_2_10_5_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0029-7844(03)00475-7"},{"key":"e_1_2_10_6_2","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2393-7-14"},{"key":"e_1_2_10_7_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(09)60736-4"},{"key":"e_1_2_10_8_2","doi-asserted-by":"crossref","DOI":"10.1093\/oso\/9780195108248.001.0001","volume-title":"Cost\u2010Effectiveness in Health and Medicine","author":"Gold MR","year":"1996"},{"key":"e_1_2_10_9_2","doi-asserted-by":"crossref","DOI":"10.1093\/oso\/9780198529446.001.0001","volume-title":"Methods for the Economic Evaluation of Health Care Programmes","author":"Drummond MF","year":"2005"},{"key":"e_1_2_10_10_2","volume-title":"Statline Consumer Pricing Index","author":"Statistics Netherlands","year":"2009"},{"key":"e_1_2_10_11_2","volume-title":"Richtlijnen voor farmaco\u2010economisch onderzoek [Guidelines for Pharmaco\u2010economic Research]","author":"Riteco JA","year":"1999"},{"key":"e_1_2_10_12_2","doi-asserted-by":"publisher","DOI":"10.2165\/00019053-200220070-00002"},{"key":"e_1_2_10_13_2","volume-title":"Pharmacotherapeutic Compass 2000\/2001","author":"Van der Kuy A","year":"2000"},{"key":"e_1_2_10_14_2","unstructured":"Dutch Obstetrics Consortium.2009. [http:\/\/www.studies.obsgyn.nl]. Last accessed 15 October 2009."}],"container-title":["BJOG: An International Journal of Obstetrics &amp; Gynaecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1471-0528.2010.02710.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/obgyn.onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1471-0528.2010.02710.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,30]],"date-time":"2024-03-30T08:41:12Z","timestamp":1711788072000},"score":1,"resource":{"primary":{"URL":"https:\/\/obgyn.onlinelibrary.wiley.com\/doi\/10.1111\/j.1471-0528.2010.02710.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,9,14]]},"references-count":13,"journal-issue":{"issue":"13","published-print":{"date-parts":[[2010,12]]}},"alternative-id":["10.1111\/j.1471-0528.2010.02710.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1471-0528.2010.02710.x","archive":["Portico"],"relation":{},"ISSN":["1470-0328","1471-0528"],"issn-type":[{"value":"1470-0328","type":"print"},{"value":"1471-0528","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,9,14]]},"assertion":[{"value":"2010-09-14","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}